TIPS FOR PAIN MANAGEMENT IN THE ED - DR. EMILY AUSTIN UHN EMERGENCY MEDICINE CONFERENCE - MYCONFERENCE SUITE
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Tips for Pain Management in the ED (that don’t involve an opioid) Dr. Emily Austin St. Michael’s Hospital; Ontario Poison Centre UHN Emergency Medicine Conference November 8, 2018
Pain is a chief complaint in > 50% of ED presentations (Cordell AM J EM 2002) https://www.aliem.com/
Non-pharmacologic strategies Ann Emerg Med. 2017;70:446-448. Patient-centered communication Physical interventions Ice, heat Topical coolant sprays Recommendations for activity, exercise Relaxation techniques
Opioids Adverse effects Respiratory depression Hypotension Bradycardia Nausea, vomiting Oversedation https://www.poison.org/
Outline 4 cases of acute pain in the ED: Sub-dissociative dose ketamine NSAIDs Regional nerve blocks Haloperidol https://smhttp-ssl-41526.nexcesscdn.net
Ketamine is an NMDA receptor antagonist *other receptor interactions as well https://encrypted-tbn0.gstatic.com
http://www.joacp.org/articles/2016/32/
Analgesic: 0.1-0.3 mg/kg Partially dissociated: 0.4 - 0.8 mg/kg Dissociated: > 0.7 mg/kg http://emupdates.com
Studies on sub-dissociative dose Ketamine for ED analgesia Motov 2018 Ahmadi 2014 Bowers 2017 Andolfatto 2013 Motov 2017 Richards 2013 Sin 2017 Ahern 2013 Beik 2016 Yeaman 2013 Motov 2015 Jennings 2012 Ahern 2015 Jennings 2011 Miller 2015 Lester 2010 Beaudoin 2014 Johansson 2009 Ahern 2014 Galinski 2007 Golster 2014 Gurnani 2006 https://twitter.com/painfreeED/ June 9, 2018
Studies on sub-dissociative dose Ketamine for ED analgesia Motov 2018 Ahmadi 2014 Sub-dissociative dose Bowers 2017 Motov 2017 Andolfatto 2013 Richards 2013 ketamine is safe and Sin 2017 Beik 2016 Ahern 2013 Yeaman 2013 effective for analgesic Motov 2015 Ahern 2015 Jennings 2012 Jennings 2011 use in EDs. Miller 2015 Beaudoin 2014 Lester 2010 Johansson 2009 Ahern 2014 ACEPAnnPolicyGalinski statement 2007 EM 2018; 71: e35 Golster 2014 Gurnani 2006
Ketamine Adverse Effects Adverse effects are minor and transient when sub-dissociative doses given EMERGENCE REACTION Nausea and vomiting Dysphoria Hallucinations Dizziness Headaches Laryngospasm Apnea Hypersalivation https://i2-prod.mirror.co.uk/
Emergency providers should disclose that SDK may trigger minor and transient adverse effects, including nausea and temporary dysphoria. ACEP Policy statement Ann EM 2018; 71: e35
Ketamine for analgesia Analgesic Dose: 0.15-0.3 mg/kg Short Infusion Continuous IV Push Infusion Over 10 - 15 Over 2 minutes minutes 0.15 mg/kg/hr, increase 2-5 mg PRN q30 min Lowest rates of adverse effects Motov AJEM 2017
One absolute contraindication *Patients with psychiatric illness are generally excluded from studies.
Geriatric population Motov et al. Am J EM 2018. Good analgesia, but more adverse events than morphine 0.1 mg/kg. https://ubisafe.org
Pregnant population Excluded from ED studies. Category C: Animal studies have shown adverse effects https://vectortoons.com/
Summary Analgesic Dose: 0.15-0.3 mg/kg IM or IV over 10 minutes Low-dose ketamine is safe and effective for analgesia in the ED. Inform patient about unpleasant side effects.
Case 2 55 yo M “10/10” left flank pain x 2 hours Remote hx of PUD https://www.aliem.com/
NSAIDs Analgesia Anti-Inflammatory Anti-pyretic http://www.previcox.com/
http://www.perioperativepain.com http://www.joacp.org/
Adverse effects limit use GI Bleed Acute kidney injury Platelet dysfunction Hypersensitivity Drug-Drug interactions Cardiovascular events
NSAIDs have an analgesic ceiling There is a dose beyond which there is no additional analgesic benefit. * there is no anti-inflammatory ceiling dose https://images.slideplayer.com/33/9421732/slides/slide_18.jpg
NSAIDs have an analgesic ceiling There is a dose beyond which there is no additional analgesic benefit. * there is no anti-inflammatory ceiling dose https://images.slideplayer.com/33/9421732/slides/slide_18.jpg
NSAIDs have an analgesic ceiling Ibuprofen 400 mg PO Ketorolac 10 mg IV Motov Ann Emerg Med 2017 There is no analgesic benefit to taking a higher dose, but more risk of adverse events. * there is no anti-inflammatory ceiling dose
Geriatric Population Caution! GI Bleed, renal injury, MI, DDI. Topical NSAIDs Screen for underlying GI, renal disease, CV risk factors Lowest dose, < 5 days. Advise patient of warning signs https://ubisafe.org
Pregnant population Not in T1, T3. https://vectortoons.com/
Summary Minimize harms by dosing NSAIDS within analgesic ceiling: Ibuprofen 400 mg PO TID Ketorolac 10 mg IV
Case 3 32 yo F “10/10” pounding right-sided headache 10 mg IV No relief despite acetaminophen, maxeran and ketorolac https://www.aliem.com/
Regional nerve blocks Directed analgesia Less systemic side effects Decreased length of stay Decreased morbidity (delirium)
Sphenopalatine ganglion block for headaches Cotton-tipped applicator + Lidocaine or bupivicaine + 15 minutes https://www.aliem.com/
Sphenopalatine ganglion block for headaches Cotton-tipped applicator + Lidocaine or bupivicaine + 15 minutes https://www.aliem.com/
Sphenopalatine ganglion block for headaches Non-invasive, well tolerated Geriatric Pregnancy Not first line https://www.aliem.com/
Summary Sphenopalatine ganglion block can be a useful adjunct for migraine pain management.
Case 4 44 yo M, T1 DM “10/10” diffuse abdominal pain, multiple episodes vomiting Many previous admissions for similar presentation https://www.aliem.com/
Haloperidol Antipsychotic Dopamine inhibition in brain & chemoreceptor trigger zone (?other complicated mechanisms)
Haloperidol 5 mg IM or IV Ramirez AJEM 2017 Lower rates of hospital admission Lower opioid dosing
Haloperidol 5 mg IM or IV Migraine Gaffigan JEM 2015 Gastroparesis Ramirez AJEM 2017, Roldan AEM 2017 Cannabinoid hyperemesis syndrome Hickey AJEM 2013 Opioid tolerant patients Richards JEM 2011, Strayer
Summary Haloperidol 5 mg IV or IM for analgesia in select clinical settings.
Take-Home Points Sub-dissociative dose Ketamine for analgesia 0.15-0.3 mg/kg IM or IV over 10 minutes Minimize harms by dosing within analgesic ceiling: Ibuprofen 400 mg PO TID Ketorolac 10 mg IV Sphenopalatine ganglion block can be a useful adjunct for migraine pain management. Haloperidol 5 mg IV or IM for analgesia in select clinical settings.
Acknowledgments Anne Sylvestre Dr. Reuben Strayer
You can also read